Guggenheim Investments Exchange-Traded Funds Declare

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim Investments Exchange-Traded Funds Declare Monthly Distributions

NEW YORK, Nov. 28, 2014 (GLOBE NEWSWIRE) -- Guggenheim Investments, the investment management division of Guggenheim Partners, today announced that the following Guggenheim exchange-traded funds ("ETFs") have declared distributions. The table below summarizes the distribution for each ETF.

Distributions Schedule

Ticker
Exchange Traded Fund Name
Ex-Date
Record
Date
Payable
Date
Total Rate Per
Share
BSCE Guggenheim BulletShares 2014 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0003
BSCF Guggenheim BulletShares 2015 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0130
BSCG Guggenheim BulletShares 2016 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0197
BSCH Guggenheim BulletShares 2017 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0264
BSCI Guggenheim BulletShares 2018 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0271
BSCJ Guggenheim BulletShares 2019 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0336
BSCK Guggenheim BulletShares 2020 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0398
BSCL Guggenheim BulletShares 2021 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0455
BSCM Guggenheim BulletShares 2022 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0504
BSCN Guggenheim BulletShares 2023 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0492
BSCO Guggenheim BulletShares 2024 Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0524
BSJE Guggenheim BulletShares 2014 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0133
BSJF Guggenheim BulletShares 2015 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0696
BSJG Guggenheim BulletShares 2016 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0779
BSJH Guggenheim BulletShares 2017 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0800
BSJI Guggenheim BulletShares 2018 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0901
BSJJ Guggenheim BulletShares 2019 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0863
BSJK Guggenheim BulletShares 2020 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0950
BSJL Guggenheim BulletShares 2021 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0774
BSJM Guggenheim BulletShares 2022 High Yield Corporate Bond ETF 12/1/14 12/3/14 12/5/14 $0.0963
GSY Guggenheim Enhanced Short Duration ETF 1 12/1/14 12/3/14 12/5/14 $0.0429
1 On September 30, 2013, Guggenheim Enhanced Short Duration Bond ETF changed its name to Guggenheim Enhanced Short Duration ETF.

Past performance is not indicative of future performance. To the extent any portion of the distribution is estimated to be sourced from something other than income, such as return of capital, the source would be disclosed on a Section 19(a)-1 letter located on the Fund's website under the "Literature" tab. Distributions may be comprised of sources other than income, which may not reflect actual fund performance.

For more information, please visit http://www.guggenheiminvestments.com/products/etf .

About Guggenheim Investments

Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, and manages more than $194.2 billion 2 in assets across fixed income, equity, and alternatives. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 250+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification and attractive long-term results.

Read a fund's prospectus and summary prospectus (if available) carefully before investing. It contains the fund's investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. Obtain a prospectus and summary prospectus (if available) at http://guggenheiminvestments.com or call 800.820.0888.

The referenced funds are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Guggenheim Funds Investment Advisors, LLC ("GFIA") and Guggenheim Partners Investment Management ("GPIM"), the investment advisors to the referenced funds. Guggenheim Funds Distributors, LLC, is affiliated with Guggenheim, GFIA and GPIM.

2 Guggenheim Investments total asset figure is as of 9/30/2014. The assets include leverage of $12.141B for assets under management and $0.465B for assets for which we provide administrative services. Guggenheim Investments represents the following affiliated investment management businesses: GS GAMMA Advisors, LLC, Guggenheim Aviation, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners India Management, Guggenheim Real Estate, LLC, Security Investors, LLC and Transparent Value Advisors, LLC.

Media Contact Ivy McLemore Director of Intermediary Communications Guggenheim Investments (212) 518-9859

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s Second IND Adds Proof to Its Glue Platform

Updated Category News Views 25

Two IND acceptances from one long-running alliance is not nothing, especially in a drug-discovery business where plenty of polished platform talk never makes it to the clinic. Evotec has cleared that modest but meaningful bar again with Bristol Myers Squibb: a second molecular-glue candidate has received FDA acceptance for an Investigational New Drug application. The...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 125

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital

Updated Category News Views 154

Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....

Continue Reading
WeWalk Brings Diabetes Support Back to Dubai Science Park

Updated Category News Views 32

Before sunrise on 21 November, a 3.5 km route in Dubai Science Park will carry a purpose bigger than sneakers and weekend fitness. WeWalk is returning for its seventh edition, with TECOM Group PJSC and Dubai Charity Association again putting the event behind support for children living with diabetes. That deserves to be said plainly: this is a community health effort, not...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 69

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 108

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 57

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Adecco Finds AI Value Depends on Better Work Redesign

Updated Category News Views 39

A shiny AI license is not a productivity strategy, and Adecco's latest workforce survey puts some hard numbers behind that irritation. The company surveyed 40,500 workers in 36 countries for its seventh Global Workforce of the Future report, released November 19, 2026. Its central finding is disarmingly sensible: AI produces more when companies rebuild the work around it...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 50

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 194

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading

Top 5 Most Recently Viewed Articles

AMSURG Expands Its Network with Pinnacle Surgery Center Acquisition

Updated Category News Views 950

AMSURG Expands Its Network with Pinnacle Surgery Center Acquisition AMSURG, a prominent independent leader in ambulatory surgery center services, recently achieved a significant milestone by acquiring Pinnacle Surgery Center. This acquisition boosts AMSURG's presence in the healthcare industry, particularly in providing high-quality surgical care to communities. Overview...

Continue Reading
Montauk Renewables Announces Q2 2025 Conference Call Details

Updated Category News Views 192

Montauk Renewables Schedules Q2 2025 Conference Call Montauk Renewables, Inc. (NASDAQ: MNTK), a leading renewable energy company specializing in biogas management, will host its second quarter 2025 conference call on a Thursday morning. This session is set for August 7, 2025, at 8:30 a.m. ET, where they will present their financial results for the period ending June 30,...

Continue Reading
MaxCyte Earnings Report: What Investors Should Know

Updated Category News Views 157

MaxCyte's Earnings Announcement Overview MaxCyte (NASDAQ: MXCT) is gearing up for its quarterly earnings report. Investors are keen to see the results, especially when it comes to their earnings per share (EPS) expectations. Anticipated Earnings Performance Analysts are predicting that MaxCyte will report an EPS of $-0.10. This figure is crucial as it sets the stage for...

Continue Reading
Pluxee Expands Employee Benefits with Benefício Fácil Acquisition

Updated Category News Views 239

Pluxee Strengthens Its Presence in Brazil Through Strategic Acquisition Pluxee has made a significant move to solidify its operations in Brazil by acquiring 100% of Benefício Fácil, a leading provider of employee mobility benefits. This acquisition marks a pivotal step in reinforcing Pluxee’s position within the dynamic Brazilian market. Details of the Acquisition The...

Continue Reading
Carlyle Credit Income Fund Announces Public Offering Details

Updated Category News Views 312

Carlyle Credit Income Fund Prices New Offering of Preferred Shares In a significant development in the investment community, Carlyle Credit Income Fund (the "Fund") (NYSE: CCIF) has unveiled the details of its latest public offering. The Fund has successfully priced an underwritten public offering for 1.2 million shares of its Series D Preferred Shares, which come with a...

Continue Reading